Capricor Therapeutics, Inc. (CAPR)
26.14
-0.57
(-2.13%)
USD |
NASDAQ |
Jun 08, 16:00
26.68
+0.54
(+2.07%)
After-Hours: 20:00
Capricor Therapeutics EPS Diluted (Quarterly) : -0.591 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| REGENXBIO, Inc. | -1.718 |
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| iBio, Inc. | -0.0646 |
| AbbVie, Inc. | 0.3861 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.94M |
| Total Expenses (Quarterly) | 33.94M |
| Enterprise Value | 1.283B |
| Earnings Yield | -8.85% |
| Normalized Earnings Yield | -8.848 |